4/10
08:06 am
pyxs
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Low
Report
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
3/22
11:20 am
pyxs
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $7.00 price target on the stock.
High
Report
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $7.00 price target on the stock.
3/22
11:20 am
pyxs
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $7.00 price target on the stock.
High
Report
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $7.00 price target on the stock.
3/22
10:46 am
pyxs
Rating for PYXS
High
Report
Rating for PYXS
3/22
10:46 am
pyxs
Rating for PYXS
High
Report
Rating for PYXS
2/9
07:24 am
pyxs
Rating for PYXS
High
Report
Rating for PYXS
2/9
07:11 am
pyxs
Pyxis Oncology, Inc. (NASDAQ: PYXS) is now covered by analysts at BTIG Research. They set a "buy" rating and a $8.00 price target on the stock.
High
Report
Pyxis Oncology, Inc. (NASDAQ: PYXS) is now covered by analysts at BTIG Research. They set a "buy" rating and a $8.00 price target on the stock.
1/23
09:48 am
pyxs
Rating for PYXS
Medium
Report
Rating for PYXS